Investment Rating - The report indicates an overall positive sentiment towards the new stock market, with an increase in activity and performance metrics for newly listed stocks [2][3][14]. Core Insights - The new stock market has seen increased activity, with 23 stocks recording positive weekly gains, representing 45.10% of newly listed stocks over the past six months, a significant increase from the previous 14.00% [2][14]. - In April, the ChiNext board saw an increase in first-day gains and opening valuations, while the main board experienced a decrease in these metrics [3][30]. - The report highlights specific stocks with notable performance, such as Honggong Technology on the ChiNext board, which had a first-day gain of 171.43% and an opening valuation of 26.23 times earnings [26][30]. Summary by Sections New Stock Market Activity - The report notes that in April, the ChiNext board's first-day gains and opening valuations increased, while the main board's first-day gains and valuations decreased [3][30]. - The report details that the main board's new stocks had an average first-day gain of 252.76% in April, down from 289.09% in March [38]. Key Newly Listed Stocks - The report lists key newly listed stocks since January 2023, including: - Xidian Co., Ltd. (semiconductor probe equipment) - Shengke Nano (third-party semiconductor testing laboratory) - Hongjing Optoelectronics (sports cameras and automotive optical lenses) [48][50]. Upcoming and Approved New Stocks - As of April 18, 2025, 18 companies have received approval from the China Securities Regulatory Commission, including: - Weigao Blood Purification (medical blood purification products) - Yitang Co., Ltd. (dry glue removal and rapid heat treatment equipment) [46][47]. - The report also mentions that there are currently no newly issued stocks awaiting listing [47]. Performance Metrics - The report provides various performance metrics, including: - The ChiNext board's first-day price-to-earnings (P/E) ratio decreased to 14.18 times in April from 17.56 times in March [30]. - The main board's first-day P/E ratio was 15.13 times in April, down from 18.17 times in March [38]. Market Trends - The report indicates that the near-term newly listed stock index is at a discount compared to the ChiNext board, with a ratio of 0.86, down from 0.90 [43]. - The report emphasizes the upward trend in the ChiNext board's valuation metrics, contrasting with the downward trend in the main board's metrics [43].

Group 1 - The new stock market activity has decreased, with the first-day price increase of new stocks on the Sci-Tech Innovation Board declining, while the opening board valuation has increased [1][13][17] - In March, the Sci-Tech Innovation Board's Shengke Nano was listed, achieving a first-day price increase of 241.41% and an opening board valuation of 154.01 times [1][17] - The ChiNext Board saw the listing of Zhejiang Huaye, Zhejiang Huayuan, and Xidian shares, with some stocks experiencing significant declines [1][25] Group 2 - The new stock issuance PE ratio for the Sci-Tech Innovation Board increased to 42.64 times in March, compared to 23.30 times in January [19][36] - The ChiNext Board's new stock issuance PE ratio rose to 17.56 times in March, up from 17.14 times in February [26] - The main board's new stock issuance PE ratio increased to 18.17 times in March, compared to 18.88 times in February [36] Group 3 - The report highlights key newly listed stocks since January 2023, including Shengke Nano and Hongjing Optoelectronics, which are recommended for attention [49] - The report lists 19 companies that have received approval from the China Securities Regulatory Commission, including Weigao Blood Purification and Yitang Technology, which are considered promising [45][46] - The report provides a detailed overview of the market position and competitive landscape of Shengke Nano, emphasizing its leading status in the semiconductor testing and analysis industry [56][57]